[HTML][HTML] Transcriptional regulation of metabolic pathways via lipid-sensing nuclear receptors PPARs, FXR, and LXR in NASH

M Cariello, E Piccinin, A Moschetta - Cellular and molecular …, 2021 - Elsevier
Abstract Non-Alcoholic Fatty Liver Disease (NAFLD) comprises a wide spectrum of liver
injuries from simple steatosis to steatohepatitis and cirrhosis. Non-Alcoholic Steatohepatitis …

[HTML][HTML] The role of nuclear receptors in the pathogenesis and treatment of non-alcoholic fatty liver disease

Z Yang, A Danzeng, Q Liu, C Zeng, L Xu… - … Journal of Biological …, 2024 - ncbi.nlm.nih.gov
Non-alcoholic fatty liver disease (NAFLD) is a global health burden closely linked to insulin
resistance, obesity, and type 2 diabetes. The complex pathophysiology of NAFLD involves …

[HTML][HTML] Nuclear receptors and transcriptional regulation in non-alcoholic fatty liver disease

Y Xiao, M Kim, MA Lazar - Molecular Metabolism, 2021 - Elsevier
Background As a result of a sedentary lifestyle and excess food consumption in modern
society, non-alcoholic fatty liver disease (NAFLD) characterized by fat accumulation in the …

[HTML][HTML] A new perspective on NAFLD: Focusing on the crosstalk between peroxisome proliferator-activated receptor alpha (PPARα) and farnesoid X receptor (FXR)

S Zhou, H You, S Qiu, D Yu, Y Bai, J He, H Cao… - Biomedicine & …, 2022 - Elsevier
Nonalcoholic fatty liver disease (NAFLD) is primarily caused by abnormal lipid metabolism
and the accumulation of triglycerides in the liver. NAFLD is also associated with hepatic …

Nonalcoholic fatty liver disease: pathogenesis and potential for nuclear receptors as therapeutic targets

J George, C Liddle - Molecular Pharmaceutics, 2008 - ACS Publications
Nonalcoholic fatty liver disease (NAFLD) is a consequence of insulin resistance
encompassing a spectrum that extends from simple hepatic steatosis through to …

Nuclear receptor modulation for the treatment of nonalcoholic fatty liver disease

CD Fuchs, SA Traussnigg… - Seminars in liver …, 2016 - thieme-connect.com
Nuclear receptors (NRs) are ligand-activated transcriptional regulators of several key
metabolic processes including hepatic lipid and glucose metabolism, bile acid homeostasis …

Nuclear receptors and nonalcoholic fatty liver disease

MC Cave, HB Clair, JE Hardesty, KC Falkner… - … et Biophysica Acta (BBA …, 2016 - Elsevier
Nuclear receptors are transcription factors which sense changing environmental or
hormonal signals and effect transcriptional changes to regulate core life functions including …

[HTML][HTML] PPAR alpha as a metabolic modulator of the liver: role in the pathogenesis of nonalcoholic steatohepatitis (NASH)

S Todisco, A Santarsiero, P Convertini, G De Stefano… - Biology, 2022 - mdpi.com
Simple Summary In the context of liver disease, one of the more growing public health
problems is the transition from simple steatosis to non-alcoholic steatohepatitis. Profound …

[HTML][HTML] The role of lipid sensing nuclear receptors (PPARs and LXR) and metabolic lipases in obesity, diabetes and NAFLD

ED Dixon, AD Nardo, T Claudel, M Trauner - Genes, 2021 - mdpi.com
Obesity and type 2 diabetes mellitus (T2DM) are metabolic disorders characterized by
metabolic inflexibility with multiple pathological organ manifestations, including non …

Nuclear receptors, inflammation, and liver disease: insights for cholestatic and fatty liver diseases

M Arrese, SJ Karpen - Clinical Pharmacology & Therapeutics, 2010 - Wiley Online Library
Members of the nuclear receptor (NR) superfamily of ligand‐activated transcription factors
are players of substantial relevance in the regulation of hepatic gene expression. NRs direct …